[Cancer of the prostate: the markers other than prostatic acid phosphatase].
The biological diagnosis of prostatic carcinoma in relation with benign prostatic hypertrophy is essentially realized by the evaluation of plasma PAP or medullar PAP, the increase of which rises to 70% of the cases. This evaluation contains also other biochemical markers such as CK-BB, glucose-6-phosphate dehydrogenase, LDH 5 or alkaline phosphatase. The elevation of urinary polyamines is also correlated with the evolution of carcinoma. Other markers have been recently described such as PSA, useful both by evaluation in serum and by its identification on biopsy in histopathology. This exploration could be completed by the evaluation of androgenic receptors and of circulating androgens.
G
G
Soula
D000469:Alkaline Phosphatase / Q000097:blood; D000728:Androgens / Q000097:blood; D000951:Antigens, Neoplasm / Q000032:analysis; D003402:Creatine Kinase / Q000097:blood; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D006801:Humans; D007527:Isoenzymes; D008297:Male; D011073:Polyamines / Q000032:analysis; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000201:enzymology / Q000652:urine; D011944:Receptors, Androgen / Q000032:analysis
D000728:Androgens; D000951:Antigens, Neoplasm; D007527:Isoenzymes; D011073:Polyamines; D011944:Receptors, Androgen; D005954:Glucosephosphate Dehydrogenase; D003402:Creatine Kinase; D000469:Alkaline Phosphatase; D017430:Prostate-Specific Antigen
Cancer de la prostate: les marqueurs autres que la phosphatase acide prostatique.